$Novo Nordisk AS(NVO.US)The only reason to still hold it is because it's cheap enough and has a high dividend, but from a product strength perspective, it's really shocking. The product is being completely suppressed and chased by Eli Lilly. Especially the oral weight-loss drugs; Eli Lilly's have better weight-loss effects and more flexible dosing methods. Is there really someone who would choose to endure needles when they have pills available?
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
